| EKSCX | HBLAX | EKSCX / HBLAX | |
| Total Expense Ratio | 1.59 | 0.89 | 179% |
| Annual Report Gross Expense Ratio | 1.85 | 0.89 | 208% |
| Fund Existence | 34 years | 20 years | - |
| Gain YTD | 4.470 | 4.636 | 96% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000 | 2000 | 50% |
| Min. Initial Investment IRA | 250 | 2000 | 13% |
| Net Assets | 544M | 11.1B | 5% |
| Annual Yield % from dividends | 4.04 | 3.15 | 128% |
| Returns for 1 year | 10.75 | 5.37 | 200% |
| Returns for 3 years | 37.90 | 18.09 | 210% |
| Returns for 5 years | 26.55 | 5.69 | 466% |
| Returns for 10 years | 55.25 | 39.35 | 140% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSEAX | 83.56 | 1.66 | +2.03% |
| Fidelity Emerging Asia | |||
| FEQJX | 15.89 | 0.08 | +0.51% |
| Fidelity Advisor Hedged Equity I | |||
| WSTRX | 64.63 | 0.17 | +0.26% |
| Nomura Science and Technology R | |||
| LVAMX | 11.25 | N/A | N/A |
| LSV US Managed Volatility Investor | |||
| CEIZX | 14.86 | -0.03 | -0.20% |
| Manning & Napier Callodine Equity Inc Z | |||